More specifically, these studies attribute an increased risk for the development of glioma to genetically increased leukocyte telomere length and identify also numerous polymorphisms in telomere-regulating genes, including, among others, members of the shelterin complex, such as POT1, and the TERT and TERC subunits of telomerase itself. This evidence concerns the gene POT1 and central nervous system cancer.